GlassScriptPhysician profile
Diane Marie Learn
NPI 1114077096
$2,329.73
in general payments reported to CMS, 2019-2025
14 companies · $582 in 2025
The $582 reported for 2025 was more than what a typical Medical provider received nationally (typical 2025 total: $213).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $243 · 2022: $207 · 2023: $560 · 2024: $738 · 2025: $582.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,880.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,880.33 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $503.75 | 2021-2025 | Eterna, Proclaim |
| Collegium Pharmaceutical, INC. | $349.27 | 2023-2024 | Belbuca, Xtampza |
| Amgen INC. | $249.99 | 2025 | Krystexxa |
| Astrazeneca Pharmaceuticals LP | $245.84 | 2024-2025 | Airsupra, Farxiga |
| Biodelivery Sciences International, INC. | $167.72 | 2021 | |
| Averitas Pharma INC. | $153.42 | 2023-2024 | Qutenza |
| Verona Pharma, INC. | $125.00 | 2025 | Ohtuvayre |
| Novo Nordisk INC | $125.00 | 2024 | Wegovy |
| Neurelis, INC. | $118.59 | 2023 | Valtoco |
| Axsome Therapeutics, INC. | $117.32 | 2024 | Auvelity |
| Bayer Healthcare Pharmaceuticals INC. | $77.48 | 2024 | |
| Si-Bone, INC. | $54.10 | 2022 | |
| Medtronic, INC. | $25.32 | 2024 | Intellis Adaptivestim |
| Pfizer INC. | $16.93 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Diane Learn listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.